Prevalence of ERG expression and PTEN loss in a Brazilian prostate cancer cohort.

This study contributes with the discussion about the development of the molecular profiling of prostate cancer. The further development of similar studies could help in stratifying specific risk groups, leading to a more personalized therapeutic decision for prostate cancer treatment.
PMID: 31826177 [PubMed - in process]

Source: Braz J Med Biol Res - December 12, 2019 Category: Research Authors: Morais CE, Gurgel DC, Teixeira AC, Mattos TVA, Silva AVAD, Tavora F Tags: Braz J Med Biol Res Source Type: research